Skip to main content

Advertisement

Log in

Is mastectomy with immediate reconstruction safe for patients undergoing neoadjuvant chemotherapy? A nationwide study from Korean Breast Cancer Society

  • Original Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Purpose

In this study, we compared the prognoses of patients who underwent mastectomy with immediate breast reconstruction (IBR) after neoadjuvant chemotherapy with those who underwent mastectomy.

Methods

This retrospective study included 87,995 patients who were surgically treated for primary breast cancer between 2008 and 2014. We compared the three groups of patients who were divided based on the following surgeries: breast-conserving surgery (BCS), mastectomy, and mastectomy with IBR.

Results

Of the 3295 patients who were treated with neoadjuvant chemotherapy, 482 patients achieved a pathological complete response (pCR) and 2813 patients did not (non-pCR). In survival analysis of the pCR patients, the 5-year Overall Survival (5 yr OS) between those who underwent mastectomy with IBR and mastectomy (P = 0.639) In the non-pCR group, 5 yr OS of the mastectomy with IBR group was 90.0%, while those of the mastectomy group was 84.4% in patients with clinical stage II (P = 0.032). In a multivariate analysis by Cox regression method revealed that the prognoses of the patients who underwent mastectomy with IBR were not different from those of patients who underwent mastectomy group in both groups (the pCR group and the non-pCR group).

Conclusion

In the pCR group, the prognoses of patients who underwent mastectomy with IBR were not different from those of patients who underwent mastectomy. In the non-pCR group, women in the mastectomy with IBR group had shown worse prognoses than the mastectomy group in advanced clinical stage. Appropriate operation should be determined depending on the status of individualized patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ananian P, Houvenaeghel G, Protiere C, Rouanet P, Arnaud S, Moatti JP, et al. Determinants of patients’ choice of reconstruction with mastectomy for primary breast cancer. Ann Surg Oncol. 2004;11:762–71.

    Article  CAS  Google Scholar 

  2. Bezuhly M, Temple C, Sigurdson LJ, Davis RB, Flowerdew G, Cook EF Jr. Immediate postmastectomy reconstruction is associated with improved breast cancer-specific survival: evidence and new challenges from the Surveillance, Epidemiology, and End Results database. Cancer. 2009;115:4648–54.

    Article  Google Scholar 

  3. Nedumpara T, Jonker L, Williams MR. Impact of immediate breast reconstruction on breast cancer recurrence and survival. Breast. 2011;20:437–43.

    Article  Google Scholar 

  4. Hong KY, Son Y, Chang H, Jin US. Trends in breast reconstruction: implications for the National Health Insurance Service. Arch Plast Surg. 2018;45:239–45.

    Article  Google Scholar 

  5. Noone RB, Murphy JB, Spear SL, Little JW 3rd. A 6-year experience with immediate reconstruction after mastectomy for cancer. Plast Reconstr Surg. 1985;76:258–69.

    Article  CAS  Google Scholar 

  6. Georgiade GS, Riefkohl R, Cox E, McCarty KS, Seigler HF, Georgiade NG, et al. Long-term clinical outcome of immediate reconstruction after mastectomy. Plast Reconstr Surg. 1985;76:415–20.

    Article  CAS  Google Scholar 

  7. Spyrou GE, Titley OG, Cerqueiro J, Fatah MF. A survey of general surgeons’ attitudes towards breast reconstruction after mastectomy. Ann R Coll Surg Engl. 1998;80:178–83.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Alderman AK, Hawley ST, Waljee J, Morrow M, Katz SJ. Correlates of referral practices of general surgeons to plastic surgeons for mastectomy reconstruction. Cancer. 2007;109:1715–20.

    Article  Google Scholar 

  9. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 1998;16:2672–85.

    Article  CAS  Google Scholar 

  10. Mougalian SS, Soulos PR, Killelea BK, Lannin DR, Abu-Khalaf MM, DiGiovanna MP, et al. Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States. Cancer. 2015;121:2544–52.

    Article  Google Scholar 

  11. Clough KB, Acosta-Marin V, Nos C, Alran S, Rouanet P, Garbay JR, et al. Rates of neoadjuvant chemotherapy and oncoplastic surgery for breast cancer surgery: a French National Survey. Ann Surg Oncol. 2015;22:3504–11.

    Article  Google Scholar 

  12. Vugts G, Maaskant-Braat AJ, Nieuwenhuijzen GA, Roumen RM, Luiten EJ, Voogd AC. Patterns of care in the administration of neo-adjuvant chemotherapy for breast cancer. A population-based study. Breast J. 2016;22:316–21.

    Article  CAS  Google Scholar 

  13. Monrigal E, Dauplat J, Gimbergues P, Le Bouedec G, Peyronie M, Achard JL, et al. Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study. Eur J Surg Oncol. 2011;37:864–70.

    Article  CAS  Google Scholar 

  14. Harnett A, Smallwood J, Titshall V, Champion A, Guideline Development G. Diagnosis and treatment of early breast cancer, including locally advanced disease—summary of NICE guidance. BMJ (Clin Res edn) 2009;338:b438-b.

  15. Patani N, Mokbel K. Oncological and aesthetic considerations of skin-sparing mastectomy. Breast Cancer Res Treat. 2008;111:391–403.

    Article  Google Scholar 

  16. Noguchi M, Earashi M, Ohta N, Kitagawa H, Kinoshita K, Thomas M, et al. Mastectomy with and without immediate breast reconstruction using a musculocutaneous flap. Am J Surg. 1993;166:279–83.

    Article  CAS  Google Scholar 

  17. McCarthy CM, Pusic AL, Sclafani L, Buchanan C, Fey JV, Disa JJ, et al. Breast cancer recurrence following prosthetic, postmastectomy reconstruction: incidence, detection, and treatment. Plast Reconstr Surg. 2008;121:381–8.

    Article  CAS  Google Scholar 

  18. Petit JY, Gentilini O, Rotmensz N, Rey P, Rietjens M, Garusi C, et al. Oncological results of immediate breast reconstruction: long term follow-up of a large series at a single institution. Breast Cancer Res Treat. 2008;112:545–9.

    Article  CAS  Google Scholar 

  19. Le GM, O’Malley CD, Glaser SL, Lynch CF, Stanford JL, Keegan TH, et al. Breast implants following mastectomy in women with early-stage breast cancer: prevalence and impact on survival. Breast Cancer Res. 2005;7:R184–93.

    Article  Google Scholar 

  20. Hormbrey E, Han C, Roberts A, McGrouther DA, Harris AL. The relationship of human wound vascular endothelial growth factor (VEGF) after breast cancer surgery to circulating VEGF and angiogenesis. Clin Cancer Res. 2003;9:4332–9.

    CAS  PubMed  Google Scholar 

  21. Curigliano G, Petit JY, Bertolini F, Colleoni M, Peruzzotti G, de Braud F, et al. Systemic effects of surgery: quantitative analysis of circulating basic fibroblast growth factor (bFGF), Vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-beta) in patients with breast cancer who underwent limited or extended surgery. Breast Cancer Res Treat. 2005;93:35–40.

    Article  CAS  Google Scholar 

  22. Aurilio G, Bagnardi V, Graffeo R, Nole F, Petit JY, Locatelli M, et al. Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer? Anticancer Res. 2014;34:6677–83.

    PubMed  Google Scholar 

  23. Kneubil MC, Brollo J, Botteri E, Curigliano G, Rotmensz N, Goldhirsch A, et al. Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction. Eur J Surg Oncol. 2013;39:260–5.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This article was supported by the research grant of the Korean Breast Cancer Society and the Chungbuk National University Hospital in 2019.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Soo Youn Bae.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

For this type of study, informed consent was not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (XLSX 60 KB)

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, S., Jeong, J., Han, W. et al. Is mastectomy with immediate reconstruction safe for patients undergoing neoadjuvant chemotherapy? A nationwide study from Korean Breast Cancer Society. Breast Cancer 28, 874–883 (2021). https://doi.org/10.1007/s12282-021-01223-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-021-01223-2

Keywords

Navigation